Who Are We?
NebulaNeuro, Inc. was founded in February 2025 under the leadership of Professor Read Montague of the Fralin Biomedical Research Institute at Virginia Tech.
We are an early stage, pre-seed biotechnology company pioneering the first-ever technology for measuring neurotransmitters, such as dopamine, serotonin, and norepinephrine, in the human brain.
Mission: to translate cutting-edge human neurotransmitter measurements into a viable technology for improving the human condition.
Belief: that state of the art, real-time neurotransmitter measurements can improve people’s lives from day-to-day wellness tracking
to improving early diagnosis and treatment for neurological and psychiatric disease.
Goal: to transform our research-grade system into a regulatory-approved, commercial product anchored in multiple peer-reviewed publications.
Why Neurotransmitters?
We all have some notion that our brains make us who we are.
However, an interesting thing about brains is that they all generally look the same–
so how is it something so uniquely ‘you’ looks like everyone else?
It is because in the tissue of your brain you have a chemical orchestra
playing a beautiful symphony that is you.
This chemical orchestra consists of molecules called neurotransmitters– many of which
have become quite known in popular culture such as dopamine and serotonin.
These molecules work together to control your moods, thoughts, and behavior.
Until Now There Has Not Been A Reliable Way to Measure Neurotransmitters in Humans.
Our novel technology aims to better the human condition by allowing us to better
understand ourselves and our diseases through neurotransmission.
How Does it Work?
Utilizing artificial intelligence, we have enhanced pre-existing technologies to enable
sub-second, simultaneous measurement of multiple neurotransmitters in humans.
The core methods behind this platform are protected by 3 pending patents,
covering our machine-learning-based extraction of neurochemical signals.
These patents ensure that the foundation of our technology is both unique and secure.
Where Does it Happen?
- In the clinic: during deep brain stimulation surgery.
- In the clinic: during phase II epilepsy monitoring.
- In healthy people: via a small nasal electrode.
